Johnson & Johnson (JNJ) Change in Accured Expenses (2009 - 2026)

Johnson & Johnson has disclosed Change in Accured Expenses across 18 years of filings, most recently posting $2.3 billion for Q2 2026.

• In Q2 2026, Change in Accured Expenses rose 297.77% year-over-year to $2.3 billion; the TTM figure through Jun 2026 stood at -$1.4 billion (down 10.91% YoY), while the FY2025 annual figure was -$5.7 billion, down 451.45% from the prior year.
• Change in Accured Expenses came in at $2.3 billion for Q2 2026 at Johnson & Johnson, up from -$3.9 billion in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $6.3 billion in Q2 2023 to a low of -$6.5 billion in Q1 2025.
• Average Change in Accured Expenses over 5 years is -$184.2 million, with a median of -$427.5 million recorded in 2024.
• Year-over-year, Change in Accured Expenses soared 8217.07% in 2023 and plunged 162.14% in 2025.
• Over 5 years, Change in Accured Expenses stood at -$2.8 billion in 2022, then surged by 218.14% to $3.3 billion in 2023, then slumped by 132.81% to -$1.1 billion in 2024, then surged by 145.7% to $499.0 million in 2025, then jumped by 364.73% to $2.3 billion in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $2.3 billion in Q2 2026, -$3.9 billion in Q1 2026, and $499.0 million in Q4 2025.